Nivolumab for relapsed or refractory hodgkin lymphoma experience in Turkey

Basit Öğe Kaydı
dc.authorid0000-0003-1237-8281
dc.contributor.authorFerhanoğlu, Burhan
dc.contributor.authorBeköz, Hüseyin Saffet
dc.contributor.authorKaradurmuş, Nuri
dc.contributor.authorPaydaş, Semra
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorTürker, Alev
dc.contributor.authorToptaş, Tayfur
dc.contributor.authorFıratlı Tuğlular, Tülin
dc.contributor.authorTekgündüz, Emre
dc.contributor.authorKaya, Ali Hakan
dc.contributor.authorTaştemir, N.
dc.contributor.authorArat, Mutlu
dc.contributor.authorPepedil Tanrıkulu, Funda
dc.contributor.authorÖzkocaman, Vildan
dc.contributor.authorAbalı, Hüseyin
dc.contributor.authorTurgut, Mehmet
dc.contributor.authorKaynar, Leylagül
dc.contributor.authorKaradoğan, İhsan
dc.contributor.authorÖzbalak, Murat
dc.contributor.authorÖzcan, Muhit
dc.contributor.authorDoğu, Mehmet Hilmi
dc.contributor.authorKabukçu Hacıoğlu, Sibel
dc.contributor.authorYıldırım, Rahsan
dc.contributor.authorBarışta, İbrahim
dc.contributor.authorDemirkaya, Metin
dc.contributor.authorKöseoğlu, Fatoş Dilan
dc.contributor.authorYüksel, Meltem Kurt
dc.contributor.authorSönmez, Mehmet
dc.contributor.authorToprak, Selami Koçak
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:56:09Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:56:09Z
dc.date.issued2017
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAIN
dc.descriptionWOS: 000404127001176
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipThe European Hematology Associationen_US
dc.identifier.citationFerhanoğlu, B., Beköz, H. S., Karadurmuş, N., Paydaş, S., Gülbaş, Z., Türker, A. ... Toprak, S. K. (2017). Nivolumab for relapsed or refractory hodgkin lymphoma experience in Turkey. 22nd Congress of the European-Hematology-Association içinde (84-85. ss.). Madrid, Spain, June 22-25, 2017.
dc.identifier.endpage85
dc.identifier.issn0390-6078
dc.identifier.issueSupplement: 2
dc.identifier.startpage84
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2595
dc.identifier.volume102
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherFerrata Storti Foundation
dc.relation.ispartof22nd Congress of the European-Hematology-Associationen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHodgkin Lymphoma
dc.subjectTurkey
dc.subjectExperience
dc.titleNivolumab for relapsed or refractory hodgkin lymphoma experience in Turkey
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Bildiri Koleksiyonu